Febuxostat - Hyperuricaemia and Gout
You are here : Home > Formulary Search > Febuxostat - Hyperuricaemia and Gout
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
Policy Statement
Evidence Review
PAD Profile
ChemicalSubstance :
Febuxostat
Indication :
Hyperuricaemia and Gout
Group Name :
Keywords :
Gout, non-purine selective inhibitor, xanthine oxidase
Brand Names Include :
Adenuric
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Febuxostat is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hyperuricaemia and Gout.
Committee Recommendations (1)
The Prescribing Clinical Network recommends the use of febuxostat in line with NICE TA 164, for the management of chronic hyperuricaemia in gout only for people who are intolerant of allopurinol (as defined in TA) or for whom allopurinol is contraindicated.
Febuxostat is considered to have a GREEN status on the traffic light system